FDA Settles With Drug Maker Amarin On Promotion Of Fish Oil Pill For Off-Label Use

Amarin announced that it has reached a settlement with FDA to continue promoting its fish oil pill Vascepa for off-label uses. At the heart of the matter is the free speech protection limit for drug companies and off-label marketing.